ReviewReproductive sciences (Thousand Oaks, Calif.)2026
The Emerging Role of Interferon-Stimulated Gene 15 (ISG15) in Pregnancy-Related Disorders.
Review in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Pregnancy-related disorders, including preterm birth, preeclampsia, recurrent spontaneous abortion, and fetal growth restriction, represent major contributors to global maternal and infant morbidity and mortality. Their pathophysiology involves complex mechanisms such as immune dysregulation, inflammatory responses, oxidative stress, and metabolic disturbances. Interferon-stimulated gene 15 (ISG15), a ubiquitin-like protein, regulates diverse biological processes-including antiviral immunity, cellular metabolism, oxidative stress, and DNA damage response-through ISGylation, which covalently conjugates ISG15 to target proteins. In recent years, the potential role of ISG15 in pregnancy-related diseases has attracted growing interest. This review systematically outlines the molecular characteristics and functions of ISG15, with a focus on its research advances in preeclampsia, recurrent spontaneous abortion, preterm birth, and fetal growth restriction. Furthermore, it discusses the potential of ISG15 as a novel biomarker or therapeutic target for pregnancy-related disorders, providing new insights for early prevention and clinical management. Collectively, this review positions ISG15 as a critical regulator in pregnancy-related pathologies and underscores its translational potential.
Indexed as
Identifiers
42082825What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.